Evidence map›Paper›PMID 14622554›Full record

ArticleAtencion primaria2003

[Study of brands in the prescription of generic drugs at 6 health centers in 2001].

G Carmona Ibáñez, J Guevara Serrano

Open access · greenAbstract readComparative StudyEnglish Abstract
In one paragraph

Article in Atencion primaria, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

G Carmona IbáñezServicio de Farmacia, Atención Primaria Area 8. Valencia. España. carmona_gis@gva.es
J Guevara Serrano
Public Risk Management Association · USUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine, through the analysis of the prescriptions billed during 2001, the brands of generic medicine prescribed by family doctors at 6 health centres in a primary care area.

designDescriptive study of medical prescription. SETTING. Primary care health area.Participants/context. 6 health centres: 3 urban and 3 metropolitan.

methodPharmaceutical prescription was analysed through the billing procedures for medical prescriptions, with the help of the administrator for GAIA pharmaceutical provision. 50% of the total generics billed in 2001, involving 7 active principles, were studied.

resultsStatistically significant differences in the prescription at the 6 centres were only found in two (omeprazole and ranitidine) of the 7 active principles. There was wide variety in the prescription of the various brands for all active principles. By assessing the involvement of the pharmaceutical industry in health centres, it was found that the smallest and the most metropolitan centres had different patterns of brand prescription.

conclusionsDetermined brands of generic drugs were prescribed more than others. Active information on brands of generic medicines, coming from professional purveyors of information for family doctors, influenced prescription more than passive information. Doctors' lack of information on a brand of generic medicine from a particular laboratory was no obstacle to their being represented just the same on pharmaceutical billing.

Indexed as

Drugs, GenericDrug CostsDrug PrescriptionsDrug UtilizationHumansPrimary Health CareSpainDrugs, Generic

Identifiers

PMID14622554
PMCPMC7669034
OpenAlexW1964192353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.